Top Recommendation from the Algorithm Based on Technical Analysis

September 29, 2010
Among top recent recommendations that can be found on the homepage of PorfolioRunner.com is a buy signal that came on 08/04/10 and recommended to open long positions for NLTX.
The fact that this buy signal was generated by Berko strategy might seem interesting to those who want to subscribe to our services but are not sure which strategies to choose. Berko strategy identifies trade opportunities on the basis of a technical analysis algorithm. NLTX are the stocks of Nile Therapeutics, Inc. (Public, NASDAQ:NLTX).
Nile Therapeutics, Inc. is a biopharmaceutical company that is engaged in developing drugs for cardiovascular diseases. Among the company’s most promising products are CD-NP which is a treatment of heart failure, and CU-NP, a natriuretic peptide that includes amino acid chains like those found in a human body. On 08/04/10 the buy price of NLTX was 0.42 dollars.
When the position was opened the stock price experienced small fluctuations until a sudden leap happened on 08/20/10. At that point the buy price was 0.53 dollars. After that NLTX stock price grew steadily and by the time the position was closed its price reached 0.75 dollars.
Nile Therapeutics August uptrend
This position brought our subscribers 78.57 percent profit in just one month.
By Brent Cole

Post new comment